您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Mecamylamine
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Mecamylamine
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Mecamylamine图片
CAS NO:60-40-2
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
美加明
产品介绍
Mecamylamine 是一种具有口服活性,非选择性,非竞争性的nAChR拮抗剂。Mecamylamine 也是一种神经节阻滞剂,可穿过血脑屏障。Mecamylamine 可用于神经疾病,高血压,抗抑郁的研究。
生物活性

Mecamylamine is an orally active, nonselective, noncompetitivenAChRantagonist. Mecamylamine is also a ganglionic blocker. Mecamylamine can across the blood-brain barrier. Mecamylamine can be used in the research of neuropsychiatric disorders, hypertension, antidepressant area[1][2][5].

IC50& Target

nAChR[1], histamine receptor[2]

体外研究
(In Vitro)

Mecamylamine (0.5-9 μM, bath administered) increases the firing frequency of identified 5-HT DRN (dorsal raphe nucleus) neurons[1].
Mecamylamine (0.5-9 μM, bath administered) increases the glutamatergic and decreases the GABAergic input of 5-HT DRN neurons[1].
Mecamylamine (1 mM, 5 min) blocks the histamine receptor and the histamine-induced contractions in helically cut strips of rabbit aorta[2].
Mecamylamine (10 μM,48 h) attenuates the effect of nicotine’s action of neuroprotection[3].
Mecamylamine (1-100 nM, 30 min) dose-dependently attenuates endothelial tube formation in HDMVECs[4].

Western Blot Analysis[3]

Cell Line:SCG neurons
Concentration:10 μM
Incubation Time:48 h
Result:Reduced the nicotine-facilitated increase in ERK1/2.
体内研究
(In Vivo)

Mecamylamine (subcutaneous pumps, 50 mg/kg/day, 2 days) inhibits choroidal neovascularization (CNV) in CNV mice model[4].
Mecamylamine (intraperitoneal injection, 0.5-1 mg/kg) has antidepressant-like effects in both the TST (tail suspension test) and FST (forced swim test) in C57BL/6J mice, which are dependent on both β2 and α7 subunits[5].

Animal Model:Choroidal neovascularization (CNV) mice model[1]
Dosage:50 mg/kg/day, 2 days
Administration:Subcutaneous pumps implanted beneath the skin of the back, 200 μL and mean pumping rate of 0.5 μL/h.
Result:Suppressed the development of CNV at Bruch’s membrane rupture sites in the absence of nicotine.
Animal Model:C57BL/6J mice[5]
Dosage:0.5-1 mg/kg
Administration:Intraperitoneal injection
Result:Had no effect in β2 knockout mice and α7 knockout mice, but decreased immobility time in wildtype littermates in the FST.
Clinical Trial
分子量

167.29

Formula

C11H21N

CAS 号

60-40-2

中文名称

美加明

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.